TY - JOUR
T1 - Design of α-S-Neoglycopeptides Derived from MUC1 with a Flexible and Solvent-Exposed Sugar Moiety
AU - Rojas-Ocáriz, Víctor
AU - Compañón, Ismael
AU - Aydillo Miguel, Carlos
AU - Castro-Loṕez, Jorge
AU - Jiménez-Barbero, Jesús
AU - Hurtado-Guerrero, Ramón
AU - Avenoza, Alberto
AU - Zurbano, María M.
AU - Peregrina, Jesús M.
AU - Busto, Jesús H.
AU - Corzana, Francisco
PY - 2016
Y1 - 2016
N2 - The use of vaccines based on MUC1 glycopeptides is a promising approach to treat cancer. We present herein several sulfa-Tn antigens incorporated in MUC1 sequences that possess a variable linker between the carbohydrate (GalNAc) and the peptide backbone. The main conformations of these molecules in solution have been evaluated by combining NMR experiments and molecular dynamics simulations. The linker plays a key role in the modulation of the conformation of these compounds at different levels, blocking a direct contact between the sugar moiety and the backbone, promoting a helix-like conformation for the glycosylated residue and favoring the proper presentation of the sugar unit for molecular recognition events. The feasibility of these novel compounds as mimics of MUC1 antigens has been validated by the X-ray diffraction structure of one of these unnatural derivatives complexed to an anti-MUC1 monoclonal antibody. These features, together with potential lack of immune suppression, render these unnatural glycopeptides promising candidates for designing alternative therapeutic vaccines against cancer.
AB - The use of vaccines based on MUC1 glycopeptides is a promising approach to treat cancer. We present herein several sulfa-Tn antigens incorporated in MUC1 sequences that possess a variable linker between the carbohydrate (GalNAc) and the peptide backbone. The main conformations of these molecules in solution have been evaluated by combining NMR experiments and molecular dynamics simulations. The linker plays a key role in the modulation of the conformation of these compounds at different levels, blocking a direct contact between the sugar moiety and the backbone, promoting a helix-like conformation for the glycosylated residue and favoring the proper presentation of the sugar unit for molecular recognition events. The feasibility of these novel compounds as mimics of MUC1 antigens has been validated by the X-ray diffraction structure of one of these unnatural derivatives complexed to an anti-MUC1 monoclonal antibody. These features, together with potential lack of immune suppression, render these unnatural glycopeptides promising candidates for designing alternative therapeutic vaccines against cancer.
U2 - 10.1021/acs.joc.6b00833
DO - 10.1021/acs.joc.6b00833
M3 - Journal article
C2 - 27305427
AN - SCOPUS:84978517876
SN - 0022-3263
VL - 81
SP - 5929
EP - 5941
JO - Journal of Organic Chemistry
JF - Journal of Organic Chemistry
IS - 14
ER -